As a result of the firm's financial results, Castle Bio raised its full-year 2025 revenue guidance to between $327 and $335 million from a range of $310 to $320 million.
Of the 30 companies in the index, 21 firms saw their share prices rise month over month, while nine saw their stock prices decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback